Drug: Buprenorphine: chronic pain clinical trials

Registry records that list "Drug: Buprenorphine" as an intervention. Being studied does not mean an intervention works or is approved.

Trials with Canadian sites

Recruiting in Canada

Registry records in total

Trials in Canada

No trial with a Canadian site lists this intervention in this snapshot.

Trials worldwide (outside Canada)

16 trials, 0 recruiting or not yet recruiting. Recruiting first.

		Phase	Countries
HOPE Consortium Trial to Reduce Pain and Opioid Use in Hemodialysis NCT04571619	Completed	Phase 2	United States	National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)	2021-01-03
Neuroimaging Study on the Effect of Transdermal Buprenorphine in Complex Regional Pain Syndrome Patients NCT03977012	Unknown status		South Korea	Seoul National University Hospital	2019-06-11
High Dosage Buprenorphine as a Drug Strategy Withdrawal Assistance of Analgesics Opioid NCT03156907	Unknown status	Phase 2	France	University Hospital, Clermont-Ferrand	2017-09-15
Buprenorphine (CAM2038) in Subjects With a Recent History of Moderate to Severe Chronic Low Back Pain NCT02946073	Completed	Phase 3	United States	Braeburn Pharmaceuticals	2016-09
Study of the Treatment of Experimental Pain in Buprenorphine Maintained Persons With Chronic Musculoskeletal Pain NCT02372591	Completed	Phase 1	United States	Johns Hopkins University	2015-08
Evaluation of the Tolerability of Switching Subjects on Chronic ATC Opioid Therapy to Buprenorphine HCl Buccal Film NCT01871285	Completed	Phase 2	United States	BioDelivery Sciences International	2013-06
Efficacy Study to Evaluate Buprenorphine HCl Buccal Film in Opioid-Experienced Subjects NCT01675167	Completed	Phase 3	United States	BioDelivery Sciences International	2012-09
Efficacy Study to Evaluate Buprenorphine HCl Buccal Film in Opioid-Naive Subjects NCT01633944	Completed	Phase 3	United States	BioDelivery Sciences International	2012-08
Efficacy and Safety Study of Buprenorphine HCl Buccal Film in Subjects With Low Back Pain NCT01256450	Completed	Phase 3	United States	BioDelivery Sciences International	2010-11
Clinical Trial of Integrated Treatment for Pain and Opioid Dependence NCT00634803	Completed	Phase 1, Phase 2	United States	Yale University	2009-09
Sublingual Buprenorphine for Chronic Pain NCT00612287	Unknown status	Phase 2	United States	National Institute on Drug Abuse (NIDA)	2009-04
Prospective Study About Clinical and Pharmacogenetic Safety of Opioid Use for Chronic Pain NCT00916890	Suspended	Phase 4	Italy	Fondazione IRCCS Policlinico San Matteo di Pavia	2009-02
Buprenorphine Transdermal System (BTDS) in Subjects w/Mod-sev Osteoarthritis (OA) Chronic Pain of Knee NCT00531427	Completed	Phase 3	United States	Purdue Pharma LP	2007-09
Norspan® Patches Versus Tramadol in Subjects With Chronic, Moderate to Severe Osteoarthritis Pain in the Hip Knee and/or Lumbar Spine NCT00426647	Completed	Phase 4	Finland	Norpharma A/S	2007-02
Safety and Efficacy of Buprenorphine Transdermal System (BTDS) in Subjects With Moderate to Severe Low Back Pain NCT00313014	Terminated	Phase 3	United States	Purdue Pharma LP	2004-02
Safety and Efficacy of Buprenorphine Transdermal System (BTDS) in Subjects With Moderate to Severe Low Back Pain NCT00313014	Terminated	Phase 3	United States	Purdue Pharma LP	2004-02

Conditions studied with this intervention

Source: ClinicalTrials.gov (US National Library of Medicine), snapshot October 2026. Check the registry for current recruiting status.